First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors

Clinical trial NCT05759949 · COMPLETED

Trial details

NCT number: NCT05759949
Sponsor: Relay Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

PIK3CA Mutation Solid Tumor, Adult HER2-negative Breast Cancer Breast Cancer Metastatic Breast Cancer Advanced Breast Cancer Unresectable Solid Tumor Hormone Receptor Positive Tumor

Start date: 2023-03-29
Primary completion: 2025-03-18
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.